Background: Pharmacy developed as a profession over several decades with the advent of apothecaries and was formalized as a profession and regulated in India beginning 1948 with the Pharmacy Act. Public health, existent for centuries was only formalized in India in 1987 through the Model Public Health act. Clinical pharmacy through structured and formalized PharmD education is fairly new to 21st century India. Clinical pharmacists play a very important role in promoting public health through various initiatives – health education, health communication, medication review, medication adherence to name a few. There is however, little recognition for clinical pharmacists as public health professionals even in developed countries where public health and pharmacy systems have co-existed for decades. In India, as both fields emerge, it is important to find synergies and open up pathways for collaboration and cooperation to ensure a stronger pool of public health field clinicians, researchers and professionals.
This session will focus on identifying the roles of public health pharmacists with focus on areas of convergence and models for collaboration and cooperation between public health and pharmacy professionals.
Session aim: Discuss strategies to enhance capacity of pharmacists to advance public health outcomes.
Session objectives: At the end of this session, participants will be able to:
• Explain how pharmacists can play pivotal roles in disease prevention and health promotion
• Identify key interdisciplinary approaches where pharmacists can help achieve optimal public health outcomes
• Discuss strategies to integrate public health practice into pharmacological training and pharmaceutical care.
Content: Throughout the world, pharmacy as a profession is evolving. In recent years, several entities involved in pharmacy education have identified public health as a major area for improvement and expansion within the core pharmacy education. Pharmacists have been identified as key healthcare professionals in achieving health goals as mentioned in Healthy People 2020. In order to successfully integrate pharmacists as public health professionals, there is a need to introduce the principles and concepts of public health early on in pharmacy education. It is equally important to create and develop opportunities for practicing pharmacists and demonstrate the impact of pharmacists toward improving the population’s health. In this session, targeted interventions to outcomes assessment, differences and similarities will be discussed with implications for effectively advancing the capacity of pharmacists to achieve public health outcomes.
References
1. Policy Statement: The Role of the Pharmacist in Public Health. Policy Number 200614. American Public Health Association. November 8, 2006.
2. Capper, SA, Sands, CD. The Vital Relationship Between Public Health and Pharmacy. The International Journal of Pharmacy Education. Fall 2006, Issue 2.
• Introduction
• The main activities of community pharmacists
• Processing of prescriptions
• Care of patients or clinical pharmacy
• Extemporaneous preparation and small-scale manufacture of medicines
• Traditional and alternative medicines
• Monitoring of drug utilization
• Responding to symptoms of minor ailments
• Informing health care professionals and the public
• Health promotion
• Domiciliary services
• Rational Use of Drugs
• Individualization of Drug
• Community Pharmacists Play Key Role in Improving Medication Safety
• Pharmacists as a Community Resource
• Conclusion
Role of pharmacist in interdepartmental communication and community health ed...akankshasrivastava121
By- Akanksha (B.pharma 4th year, Galgotias University)
Role of pharmacist, Professsion of pharmacy practice, Interdepartmental communication of pharmacist, Communication with health proffesions , with paitients , Information leaflets, Medication counselling for patient, Impact of internal dysfunction
• Introduction
• The main activities of community pharmacists
• Processing of prescriptions
• Care of patients or clinical pharmacy
• Extemporaneous preparation and small-scale manufacture of medicines
• Traditional and alternative medicines
• Monitoring of drug utilization
• Responding to symptoms of minor ailments
• Informing health care professionals and the public
• Health promotion
• Domiciliary services
• Rational Use of Drugs
• Individualization of Drug
• Community Pharmacists Play Key Role in Improving Medication Safety
• Pharmacists as a Community Resource
• Conclusion
Role of pharmacist in interdepartmental communication and community health ed...akankshasrivastava121
By- Akanksha (B.pharma 4th year, Galgotias University)
Role of pharmacist, Professsion of pharmacy practice, Interdepartmental communication of pharmacist, Communication with health proffesions , with paitients , Information leaflets, Medication counselling for patient, Impact of internal dysfunction
Teaching the history of pharmacy to young people is a challenge but it can be done if delivered in an interesting and engaging way. These slides summarize what I share with my students.
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...MerrinJoseph1
Second Pharm D , Community Pharmacy -first chapter,definition of community pharmacy,its scope and the roles and responsibilities of community pharmacist in health care of common people,Dr.Merrin Joseph,Department of pharmacy practice
Introduction to public health, definition, Preventive medicine vs public health, social medicine, community medicine, role of public health, public health practices, core activities
Teaching the history of pharmacy to young people is a challenge but it can be done if delivered in an interesting and engaging way. These slides summarize what I share with my students.
Community pharmacy-Definition ,scope and Roles and responsibilities of commun...MerrinJoseph1
Second Pharm D , Community Pharmacy -first chapter,definition of community pharmacy,its scope and the roles and responsibilities of community pharmacist in health care of common people,Dr.Merrin Joseph,Department of pharmacy practice
Introduction to public health, definition, Preventive medicine vs public health, social medicine, community medicine, role of public health, public health practices, core activities
are increasing the importance of environmental ethics has started to take pre...KhalidMdBahauddin
are increasing the importance of environmental ethics has started to take precedence making its global issue. as this issue do not respect National boundaries
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
Pharmacists in public health
1. S
Pharmacy and Public Health: Pathways
for intersection, collaboration and
cooperation
Dr. Meghana V. Aruru, Ph.D., MBA, B.Pharm
Associate Professor,
Indian Institute of Public Health – Public Health Foundation of India
Adjunct Faculty, California Northstate University
U.S. FDA Consultant
2. Health
S The World Health Organization defines Health (of an individual)
as the state of complete physical mental and social well-being and not
merely the absence of disease or infirmity.
3. Public Health
S As defined in 1976 by a Milbank Memorial Fund Commission on Higher
Education for Public Health, "Public Health is the effort organized by society
to protect, promote, and restore the people’s health. The programs, services,
and institutions involved emphasize the prevention of disease and the health
needs of the population as a whole." Higher Education for Public Health,
Milbank Memorial Fund, New York NY (1976)
S “The science and the art of preventing disease, prolonging life and promoting
health and efficiency through organized community effort.” Winslow, C. The
untilled field of public health. Mod. Med. 1920; 2:183-191.
4. What public health is not!
S Public health problems are not health problems considered
as they occur in a series of individuals presenting themselves
to a health-care provider, but are considered in the context
of a community or a population as a whole.
S The scope of public health is not infrequently misinterpreted
as primarily medical care for the underserved.
Maeshiro, R. et al. Medical education for a healthier population: reflections on
the Flexner Report from a Public Health perspective. Acad. Med. (85):2; 211-219.
(2010)
5. Public Health functions
S Micro level:
S Service is relatively direct as compared to the macro or planning level.
S For example, the director of a NCD clinic is functioning at the micro level, whereas
the individual who perceived the need in the population compared to other needs,
determined that there should be such a clinic, and allocated resources for it, is
functioning at the macro level.
S Macro level:
S Formulation of health-care policy, health-care planning, and program
implementation, direction, and evaluation, especially at the national level.
S These foci affect the practice arrangements of other health professionals. This work
also leverages change in equity/disparity issues, quality of care, and access to health
services by the population.
S Pharmacy too often ignores the macro level of public health. As a consequence
relatively few pharmacists are available as role models or decision leaders.
6. McKinlay’s Population based
Intervention model
S Downstream: Individual level interventions aimed at those with
behavioral risk factors or suffering from risk-related diseases.
Emphasis is on change, rather than prevention.
S Midstream: Population level interventions that target defined
populations in order to change and/or prevent behavioral risk
factors.
S Upstream: National and regional public policies or environmental
interventions aimed at strengthening social norms and supports of
healthy behaviors.
7. Historical Shifts
S Dramatic reductions in
mortality during the late
19th and early 20th
Century
S Clean water was
responsible for nearly
half of the total
mortality reduction in
major U.S. cities, three-
quarters of the infant
mortality reduction, and
nearly two-thirds of the
child mortality
reduction.
8. Western world approach
S The western approach of avoiding diseases, death and
disability, traditionally focused on personal hygiene and
public sanitation during the 19th Century.
S This approach, combined with better food availability paid
rich dividends in developed countries toward reducing
morbidity and mortality.
9. Catalysts for change
S Epidemiologic transition:
S Acute to Chronic diseases
S Improvements in Incidence/Prevalence of burden of Infectious diseases
S Dual burden of diseases – ID and malnutrition prevalent + Chronic disease
risk factors on the rise
S Demographic transition: population increase, shift toward ageing
population, life expectancy increase
S Health care delivery and financing transition:
S Spiraling costs of health care
S Increase in private insurance spend
S Persistent health disparities
S Migration and Displacement – e.g. recent Chennai floods
12. Indian perspective on medicine
S Enshrined in the concepts and principles of Ayurveda which means
the ‘science of life’.
S Ayurveda is one of the oldest systems of healthcare in the world.
S Ayurveda deals with both preventive and curative aspects of health.
S Health defined by WHO is very similar to concepts of Ayurveda.
13. India’s health sector
S Responsibility of State, Local and Central Government
S Service delivery established by states
S Milestones:
S Primary health centers (PHCs): 1952
S Family planning: 1952
S Green Revolution: 1967-77
S National health programs: 1957 onwards
S National Health Policy: 1982, 2002
S National Rural Health Mission: 2005
S Public Health Foundation of India: 2006
14. Public Health Foundation of
India (PHFI)
S Public-private partnership includes Indian and International
academia, state and central governments, bilateral agencies, civil
society groups
S Response to redress institutional capacity in India for strengthening
training, research and policy development in the area of public
health
15. Vision
Our vision is to strengthen India’s public health institutional and systems capability and
provide knowledge to achieve better health outcomes for all.
Mission
• Developing the public health workforce and setting standards.
• Advancing public health research and technology.
• Strengthening knowledge application and evidence-informed public health practice and
policy.
16. India’s health system
S Total expenditure on health: 5.2% GDP
S Public Health Investment: 0.9% GDP
S Budget allocation for health: 1.3% of central budget
S Government expenditure: 25%
S Out-of-pocket expenditure: 75%
How did we get here?
17. Public health before the colonial
period
S Little is known about public health activities before the
colonial period.
S Main stream system health care was Ayurveda.
S Home-based care appeared to be predominant.
S Few organised efforts or institutional care to treat diseases
and prevent deaths.
18. Public health during colonial
period
S Evolution of public health system during the colonial period
followed the same path as Great Britain.
S Public health efforts were focused largely on protecting British
civilians and army cantonments.
S Sanitation was given top priority.
S Focus was also on early detection and control of contagious
diseases – cholera and plague.
19. PH during the colonial period
S Training and Research Institutions in public health.
S Public health legislation.
S Sanitary departments
S Ascertaining local sanitary conditions.
S Vital registration.
S Monitoring disease trends.
S Vaccination programmes.
S Technical advice on control of epidemics.
20. PH during the colonial period
S Restriction of public health efforts to British civilians and
military.
S Majority of Indian masses remained deprived of the dividends of
these efforts.
S At the time of Independence, only 3 per cent households in
India had toilets.
S Water, drainage and waste disposal services were utterly lacking.
21. PH during colonial period
S Although, public health efforts were restricted to British
civilian and military establishment, they had impact on
Indian masses.
S Mortality spikes were sharply reduced.
S Mortality from cholera and plague was sharply reduced.
S Diseases like malaria and gastro-enteritis continued to take
heavy toll.
22. Public health post colonial
period
S Evolution of public health care system in Independent India
was shaped by two important factors:
S The Report of First Health Survey and Development
Committee (Bhore Committee) constituted during the colonial
rule.
S Emergence of modern medical technology for the prevention
and control of diseases, especially communicable diseases.
23. Bhore Committee
S Appointed in 1943.
S Recommended comprehensive remodeling of health services.
S Integration of preventive and curative health services at all levels.
S Hospital-based health care system.
S Development of primary health centres in two stages.
S Training in Preventive and Social Medicine.
S The short-term plan
S A PHC for every 40,000 population.
S PHC to be manned by 2 doctors, 4 PHN, 4 Midwives, 4 trained dais, 2 Sanitary
inspectors, 2 health assistants, 1 Pharmacist and 15 class IV employees.
S The long-term plan
S A primary health unit for every 10-20 thousand population with 75 beds.
S Secondary unit with 650 bed hospital.
S District unit with 2500 bed hospital.
24. PH in Independent India
S The recommendations of Bhore Committee and the availability of preventive and curative
medical technology resulted in the evolution of hospital-based public health system.
S The public health arrangements created during the colonial period were replaced by hospitals
and health centres.
S Public health services were merged with medical services. In 1952, India was the first country
to launch a national programme emphasizing family planning to stabilize the population at a
level consistent with the requirement of the national economy.
S Bhore Committee recommendations were accepted only partially:
S One primary health centre for every 30 thousand population.
S Only 6 beds in each primary health centre.
S Only one doctor.
S Truncated paramedical staff.
S The situation has remained largely unchanged.
25. Public Health in Independent India
S Since Bhore Committee, numerous committees were
constituted to evolve the public health system.
S Some of the recommendations of these committees were
adopted; some were not by the government.
S All committees retained the core of the model
recommended by the Bhore Committee.
26. Public Health in India
S Mudalliar Committee(1962)
S Strengthen PHCs before establishing new ones.
S PHC should provide preventive, promotive and curative services.
S Strengthen sub-divisional and district hospitals.
S Creation of All India Health Services.
S Chaddha Committee (1963)
S Malaria worker to function as multipurpose worker.
27. Public Health in India
S Mukherjee Committee (1965)
S Separate staff for family planning programme.
S Malaria activities to be de-linked from family planning
activities.
S Jungalwala Committee (1967)
S A unified approach for all problems instead of a segmented
approach for different problems.
S Medical care and public health programmes to be put under
charge of a single administrator.
28. Public Health in India
S Kartar Singh Committee (1973)
S Concept of MPW(M) and MPW(F).
S Shrivastav Committee (1975)
S Creation of bonds of paraprofessional and semiprofessional
health workers from within the community itself.
S Development of a “Referral Services Complex.”
S Establishment of Medical and Health Education Comission for
planning and implementing reforms on the lines of UGC
29. Public Health in India
S Bajaj Committee (1986)
S Formulation of National Medical & Health Education Policy.
S Formulation of National Health Manpower Policy.
S Educational Commission for Health Sciences.
S Health Science Universities in various states.
S Health manpower cells.
S Vocationalisation of education at 10+2 levels as regards health
related fields.
S Realistic health manpower survey.
30. Public Health System in India
S A population based normative approach is adopted for
establishing hospitals and health centres
S SHC – One for every 5000 (3000 in hilly/tribal areas)
population.
S PHC – One for every 30000 population (20000 in difficult
areas) with 4-6 indoor/observation beds.
S CHC – One for every 80-120 thousand population with 30
beds.
31. Public Health System in India
S The norms are for government institutions and rural areas
only.
S For the urban areas, no norms have been defined.
S Nearly all government civil and district hospitals and most of
the CHCs are located in the urban areas.
S Private health system? Opportunities for convergence?
32. Public Health System in India
Institution Number
SHC 145272 More than 6 SHC for each PHC, on
average
PHC 22370 More than 5 PHC for every CHC, on
average
CHC 4045
Rural hospitals 6298
Beds in rural hospitals 142396 About 23 beds per rural hospital
Urban hospitals 2774
Beds in urban hospitals 324206 About 117 beds per urban hospital
33. Public Health in India
S Focus on medical services.
S Neglect of public health services.
S No modern public health regulation.
S Lack of systematic planning.
S Poor sustainability of public health efforts.
S Absence of epidemiological and statistical skills at district and
below district level.
S No micro-level planning, no public health action.
34. Achievements through the years
Epidemiological Shifts
• Malaria (cases in million)
• Leprosy (cases per 10,000)
• Small pox (No. of cases)
• Guineaworm (No. of cases)
• Polio
1951
75
38.1
>44,887
1981
2.7
57.3
Eradicated
>39,792
29,709
2000
2.2
3.74
Eradicated
265
Infrastructure:
• SC/PHC/CHC
• Dispensaries & Hospitals
• Beds (Pvt. & Public)
• Doctors (Allopathy)
• Nursing Personnel
725
9209
117,198
61,800
18,054
57,363
23,255
569,495
2,68,700
1,43,887
1,63,181(99-RHS)
43,322
8,70,161
5,03,900
7,37,000
Source: National Health Policy, 2002
36. Current Scenario
S Resurgence of communicable diseases
S Dengue, Chikungunya etc.
S Declining public investments and expenditures in health and
healthcare
S Decline in access to basic health care services
S Rising costs of healthcare and changed economics
S Demand supply gaps (100 beds/100,000 – WHO norms:
300/100,000)
37. Continuing trends: Glass half
empty or half full?
S Value propositions:
S Stepping up of standards in medical care
S Low cost but not necessarily poor quality
S Diagnostics relatively inexpensive
S Growing incomes and literacy
S Health insurance
S Healthcare BPO
S Telemedicine: Rural population > 700 million
40. Pharmacy in Transition
S Pharmaceutical Public Health: “The application of
pharmaceutical knowledge, skills and resources to the science and
art of preventing disease, prolonging life, promoting, protecting
and improving health for all through the organised efforts of
society” (Walker, R. 2000).
S Pharmaceutical care is delivered at the individual patient level.
“Pharmaceutical care is the responsible provision of drug therapy
for the purpose of achieving definite outcomes that improve a
patient’s quality of life.” (Hepler and Strand, 1990).
41. Ironic?
S Of the four categories of health determinants at a
population level, health care provision is the least important.
Hereditary factors, environment, and lifestyle (behavior) are
all considered more important.
42. Pharmacy Education & Public
Health at Micro and Macro Levels
S “Pharmacy education has failed to recognize the potential for
pharmacists in public health …” Patricia J. Bush and Keith W.
Johnson, Where Is the Public Health Pharmacist? Am. J. Pharm.
Educ., 43,249-2S2( 1979)
43. Core elements of PH practice
Source: PharmacyHealthLink (PHLink), 2008-2009︎
1. Surveillance and assessment of the population’s
health and well being︎
2. Promoting and protecting the population’s
health and well-being︎
3. Developing quality and risk management within
evaluative frameworks (clinical effectiveness,
quality assurance, risk management, identifying
deficits of structure and process)︎
4. Collaboratively working for health, building
alliances, partnerships︎
5. Developing capacity to reduce health inequalities
(design and delivery of services)︎
︎
6. Policy and strategy development and
implementation, cyclical efforts to implement
strategies and assess the impact of those
policies on health improvement︎
7. Advocating for the public and adapting services
to better meet the needs of communities.︎
8. Strategic leadership –(reduction in inappropriate
antibiotic use; mental health)︎
9. Research and development to improve health
and well-being at a population level.︎
10. Commitment to life long learning to assure
better models equitable use, distribution and
access to resources.︎
︎
45. Developing PH Pharmacy
Policies
S Assumptions:
S Social justice
S Improve safety and reduce financial burden of treatments
S Policies to reduce costs: controlling profits, establishing profit limits,
extending prescription providers, revising Rx classifications,
emphasizing generics, establishing formularies
S Public education: lifestyles, comorbidity (elderly population?)
S PH perspective serves to maximize savings for all to increase access
and improve population health – what about profit maximization?
46. Developing PH Pharmacy
policies
S Safety as a priority:
S Active regulatory role for government?
S Litigation fears for focusing manufacturers attention on safety?
Important to align pharmacy policies with a PH perspective on
safety and costs.
47. Opportunities
S Cost-effective clinical roles for Pharmacists
S Pharmacists represent the third largest healthcare professional
group in the world. The majority of pharmacists practice in private
retail pharmacies, few in public health facilities. There is very little
published international data on the pharmacy workforce. However,
in 2006 a survey by International Pharmaceutical Federation (FIP)
revealed that the pharmacist to population ratios vary widely
throughout the world from less than 5 to over 200 pharmacists per
100,000 population – Significant potential of pharmacy knowledge
is untapped and wasted
48. Implications for education &
training
S Old paradigm: product focused
S Reports, maps and tables on health providers focus
exclusively on doctors and nurses. Pharmacists are hardly
mentioned as health professionals. They tend to be listed
“others, auxiliaries, support staff” etc.
49. Interdisciplinary approaches for
optimal PH outcomes
S Quality control & improvement
S Education & Outreach
S Counseling
S Behaviour change
S Interdisciplinary collaboration
Think global…work local
50. Questions to think about
S Are pharmacists well prepared to conduct activities within
the public health arena? – Develop PH competence
alongside clinical competence
S What roles could pharmacists play in improving physical,
financial, legislative barriers to access?
S What are the future standards of pharmacy practice? How
do we make PH pharmacy viable and sustainable? Business
models for community pharmacy?
51. Thoughts to ponder…
S In the west, PH and Pharmacy evolved independently
S PH and Pharmacy are developing in India – opportunities for
intersection and collaboration
Identified target areas:
S Pharmacoepidemiology, Pharmacovigilance
S Behavior change patterns
S Counseling and education: Medications, Lifestyle
S Surveillance
S Mapping policies for cost optimization
52. And last but not the least…
S How will Pharmacists participate in the Public Health
System to advance public health outcomes and what type of
capacity building will be needed?